Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Benedikte Serruys
Observed name:
B. Serruys
Institution:
Sanofi (Belgium)
Observed institutions:
Ablynx (Belgium),
Ghent University Hospital,
Ghent University,
Sanofi (Belgium)
OpenAlex ID:
A5004548889
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
2010
·
Sven Jähnichen
, Christophe Blanchetot
, et al.
·
Proceedings of the National Academy of Sciences
·
281
Llama‐derived single‐domain intrabodies inhibit secretion of hepatitis B virions in mice†
2008
·
Benedikte Serruys
, Freya Van Houtte
, et al.
·
Hepatology
·
63
The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo
2020
·
Anne Sofie Siebuhr
, Daniela Werkmann
, et al.
·
International Journal of Molecular Sciences
·
47
PDF
The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate
2004
·
Peter Vanlandschoot
, Freya Van Houtte
, et al.
·
Journal of General Virology
·
44
Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies
2009
·
B. Serruys
, F. Van Houtte
, et al.
·
Journal of General Virology
·
42
PDF
Contamination of a Recombinant Hepatitis B Virus Nucleocapsid Preparation with a Human B-Cell Activator
2006
·
Peter Vanlandschoot
, Freya Van Houtte
, et al.
·
Journal of Virology
·
15
The anti-ADAMTS-5 nanobody®, M6495, protects against cartilage breakdown in cartilage and synovial joint tissue explant models
2018
·
A. Siebuhr
, A.-C. Bay-Jensen
, et al.
·
Osteoarthritis and Cartilage
·
12
PDF
Pharmacokinetic and pharmacodynamic modelling of the novel anti-ADAMTS-5 nanobody M6495 using the neo-epitope ARGS as a biomarker
2018
·
J. Pereira
, I. Ottevaere
, et al.
·
Osteoarthritis and Cartilage
·
7
PDF
Safety of Nanobody® ALX-0651 targeting the G protein coupled receptor CXCR4
2012
·
Sandra De Boever
, Sandy Jacobs
, et al.
·
Toxicology Letters
·
5
Structural and symptomatic benefit of a half-live extended, systemically applied anti-ADAMTS-5 inhibitor (M6495)
2018
·
C. Brenneis
, B. Serruys
, et al.
·
Osteoarthritis and Cartilage
·
4
Translational pharmacokinetic and pharmacodynamic modelling of the anti-ADAMTS-5 NANOBODY® (M6495) using the neo-epitope ARGS as a biomarker
2024
·
Joao N.S. Pereira
, Ingrid Ottevaere
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
3
PDF
New Developments in the Use of Biomarkers in Translational Medicine
2015
·
Benedikte Serruys
, Thomas Stöhr
, et al.
·
Elsevier eBooks
Llama-derived single-domain intrabodies against the Hepatitis B Virus surface and core antigen
2009
·
Benedikte Serruys
·
Ghent University Academic Bibliography (Ghent University)
P.026 In vitro inhibition of HBsAg secretion by single-domain intrabodies
2006
·
B. Serruys
, F. Vanhoutte
, et al.
·
Journal of Clinical Virology
In vivo expressie van het humaan urokinase Plasminogeen Activator-gen en het influenza M2-gen via een hydrodynamische methode
2003
·
Benedikte Serruys
Show more works
View as search
Works count:
16
Citation count:
523
H-index:
7
I10-index:
7
Year
Topic
Type